“…Recently, neuroproteomics has become a prominent means to assess neurodegenerative conditions, and it has been found to be particularly useful for biomarker discovery (Ekegren et al, 2008;Hanrieder et al, 2009;Kochanek et al, 2008;Ottens et al, 2006Ottens et al, , 2007Zetterberg et al, 2008;Zhang et al, 2008). A number of proteomic studies have examined TBI (Agoston et al, 2009;Gao et al, 2007;Haqqani et al, 2007;Hanrieder et al, 2009;Hergenroeder et al, 2008a;Jenkins et al, 2002;Kochanek et al, 2006;Ottens et al, 2007;Prieto et al, 2008), as well as brain ischemia (Chen et al, 2007Cid et al, 2007;Dhodda et al, 2004;Focking et al, 2006;Junker et al, 2007;Koh, 2009;Sung et al, 2009;Yao et al, 2008Zhang et al, 2009), a common component of TBI.…”